163 BOOSTER SURFACTANT THERAPY BEYOND THE FIRST WEEK OF LIFE IN VENTILATED EXTREMELY LOW GESTATIONAL AGE NEONATES
Merrill, J. D., Ballard, P. L., Hibbs, A. M., Godinez, R. I., Godinez, M. H., Luan, X., Ryan, R., Reynolds, A. M., Hamvas, A., Spence, K., Courtney, S., Posencheg, M., Ades, A., Lisby, D., Ballard, R. A.
Published in Journal of investigative medicine (01.01.2006)
Published in Journal of investigative medicine (01.01.2006)
Get full text
Journal Article
Enhanced distribution of adenovirus-mediated gene transfer to lung parenchyma by perfluorochemical liquid
Lisby, D A, Ballard, P L, Fox, W W, Wolfson, M R, Shaffer, T H, Gonzales, L W
Published in Human gene therapy (20.05.1997)
Published in Human gene therapy (20.05.1997)
Get more information
Journal Article
Booster Surfactant Therapy beyond the First Week of Life in Ventilated Extremely Low Gestational Age Neonates
Merrill, J.D., Ballard, P.L., Hibbs, A.M., Godinez, R.I., Godinez, M.H., Luan, X., Ryan, R., Reynolds, A.M., Hamvas, A., Spence, K., Courtney, S., Posencheg, M., Ades, A., Lisby, D., Ballard, R.A.
Published in Journal of investigative medicine (01.01.2006)
Published in Journal of investigative medicine (01.01.2006)
Get full text
Journal Article
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
Hillmen, Peter, Prof, Robak, Tadeusz, MD, Janssens, Ann, MD, Babu, K Govind, MD, Kloczko, Janusz, MD, Grosicki, Sebastian, MD, Doubek, Michael, MD, Panagiotidis, Panagiotis, MD, Kimby, Eva, MD, Schuh, Anna, MD, Pettitt, Andrew R, MRCPath, Boyd, Thomas, MD, Montillo, Marco, MD, Gupta, Ira V, MD, Wright, Oliver, BSc, Dixon, Iestyn, BSc, Carey, Jodi L, RN BSN, Chang, Chai-Ni, MS, Lisby, Steen, MD, McKeown, Astrid, PhD, Offner, Fritz, MD
Published in The Lancet (British edition) (09.05.2015)
Published in The Lancet (British edition) (09.05.2015)
Get full text
Journal Article
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
van Oers, Marinus H J, Prof, Kuliczkowski, Kazimierz, Prof, Smolej, Lukáš, MD, Petrini, Mario, Prof, Offner, Fritz, Prof, Grosicki, Sebastian, MD, Levin, Mark-David, MD, Gupta, Ira, MD, Phillips, Jennifer, PhD, Williams, Vanessa, MS, Manson, Stephanie, PhD, Lisby, Steen, MD, Geisler, Christian, Prof
Published in The lancet oncology (01.10.2015)
Published in The lancet oncology (01.10.2015)
Get full text
Journal Article
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
Machiels, Jean-Pascal, Prof, Subramanian, Somasundaram, MD, Ruzsa, Agnes, MD, Repassy, Gabor, Prof, Lifirenko, Igor, MD, Flygare, Annika, BSc, Sørensen, Per, MSc, Nielsen, Tina, MD, Lisby, Steen, MD, Clement, Paul MJ, PhD
Published in The lancet oncology (01.04.2011)
Published in The lancet oncology (01.04.2011)
Get full text
Journal Article
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study
Furman, Richard R, Eradat, Herbert A, DiRienzo, Christine G, Hofmeister, Craig C, Hayman, Suzanne R, Leonard, John P, Coleman, Morton, Advani, Ranjana, Chanan-Khan, Asher, Switzky, Julie, Liao, Qiming M, Shah, Damini, Jewell, Roxanne C, Lisby, Steen, Lin, Thomas S
Published in The Lancet. Haematology (01.01.2017)
Published in The Lancet. Haematology (01.01.2017)
Get more information
Journal Article